MedTrace Logo

Ketamine for Low Mood States in the ER

NCT01209845 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2020-08-24

No results posted yet for this study

Summary

The investigators hope to see if a commonly used drug such as ketamine could help depressed ER patients feel better and improve their mood quickly.

Conditions

Interventions

DRUG

ketamine

intravenous ketamine(0.2 mg/kg) over 1-2 minutes IV

Sponsors & Collaborators

  • Yale University

    lead OTHER

Principal Investigators

  • Gregory L Larkin, MD · Yale University School of Medicine, Department of Emergency Medicine

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01209845 on ClinicalTrials.gov